Dementia risk was comparable between GLP1-RA versus SGLT2i in both intention-to-treat (HR 0.98, 95% CI 0.871.11
Barkley has lost a total of 85 pounds over the last few years, a transformation that has taken him from a peak post-retirement weight of 352 pounds down to approximately 267 pounds as of early 2026
Tumor progression can be influenced by metabolism, including antioxidant glutathione (GSH)
This includes utilizing powerful medications like Wegovy and Zepbound, which are leading the charge in not just treating existing conditions, but in preventing future health crises
More than 15 million American adults are estimated to take GLP-1 medications
In turn, telehealth companies began selling the drugs at prices far lower than the average $1,300 per month paid for brand-name GLP-1s